BDBM145651 US8952177, 4::US9089569, 4::US9695149, 4

SMILES: Cc1ccc(COc2ccc3nc(C4CCCC[C@H]4C(O)=O)n(Cc4ccc(Br)c(F)c4)c3c2)nc1

InChI Key: InChIKey=UUNMYGIQPWDJJC-FOIFJWKZSA-N

Data: 3 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 145651   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
5-lipoxygenase-activating protein (FLAP) (Homo sapiens (Human))	BDBM145651 (US8952177, 4 | US9089569, 4 | US9695149, 4) Show SMILES Cc1ccc(COc2ccc3nc(C4CCCC[C@H]4C(O)=O)n(Cc4ccc(Br)c(F)c4)c3c2)nc1 |r| Show InChI InChI=1S/C28H27BrFN3O3/c1-17-6-8-19(31-14-17)16-36-20-9-11-25-26(13-20)33(15-18-7-10-23(29)24(30)12-18)27(32-25)21-4-2-3-5-22(21)28(34)35/h6-14,21-22H,2-5,15-16H2,1H3,(H,34,35)/t21?,22-/m1/s1	PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	2.5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Janssen Pharmaceutica NV US Patent					Assay Description FLAP-containing membranes were prepared as was a FITC-labeled FLAP modulator (3-(3-(tert-butylthio)-1-(4-chlorobenzyl)-5-(quinolin-2-ylmethoxy)-1H-in...				US Patent US8952177 (2015) BindingDB Entry DOI: 10.7270/Q2G73CFW
					More data for this Ligand-Target Pair
5-lipoxygenase/FLAP (Homo sapiens (Human))	BDBM145651 (US8952177, 4 | US9089569, 4 | US9695149, 4) Show SMILES Cc1ccc(COc2ccc3nc(C4CCCC[C@H]4C(O)=O)n(Cc4ccc(Br)c(F)c4)c3c2)nc1 |r| Show InChI InChI=1S/C28H27BrFN3O3/c1-17-6-8-19(31-14-17)16-36-20-9-11-25-26(13-20)33(15-18-7-10-23(29)24(30)12-18)27(32-25)21-4-2-3-5-22(21)28(34)35/h6-14,21-22H,2-5,15-16H2,1H3,(H,34,35)/t21?,22-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	2.5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
JANSSEN PHARMACEUTICA NV US Patent					Assay Description The assay below is used to test the modulatory activity of compounds against FLAP. Human and mouse FLAP-encoding DNA was amplified by polymerase chai...				US Patent US9695149 (2017) BindingDB Entry DOI: 10.7270/Q2Q52MSC
					More data for this Ligand-Target Pair
5-lipoxygenase/FLAP (Homo sapiens (Human))	BDBM145651 (US8952177, 4 | US9089569, 4 | US9695149, 4) Show SMILES Cc1ccc(COc2ccc3nc(C4CCCC[C@H]4C(O)=O)n(Cc4ccc(Br)c(F)c4)c3c2)nc1 |r| Show InChI InChI=1S/C28H27BrFN3O3/c1-17-6-8-19(31-14-17)16-36-20-9-11-25-26(13-20)33(15-18-7-10-23(29)24(30)12-18)27(32-25)21-4-2-3-5-22(21)28(34)35/h6-14,21-22H,2-5,15-16H2,1H3,(H,34,35)/t21?,22-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	2.5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
JANSSEN PHARMACEUTICA NV US Patent					Assay Description The assay below is used to test the modulatory activity of compounds against FLAP. Human and mouse FLAP-encoding DNA was amplified by polymerase chai...				US Patent US9089569 (2015) BindingDB Entry DOI: 10.7270/Q23X85DB
					More data for this Ligand-Target Pair